Alm. Swislocki et al., SMOKELESS NICOTINE ADMINISTRATION IS ASSOCIATED WITH HYPERTENSION BUTNOT WITH A DETERIORATION IN GLUCOSE-TOLERANCE IN RATS, Metabolism, clinical and experimental, 46(9), 1997, pp. 1008-1012
Cigarette smoking is a major risk factor for coronary heart disease, T
o further investigate the relationship of nicotine with other cardiac
risk factors, we studied the impact of nicotine on blood pressure and
glucose tolerance. Adult male Sprague-Dawley rats were randomly assign
ed to receive nicotine or placebo pellets implanted subcutaneously, We
ight gain was controlled by pair-feeding, and was not significantly di
fferent between nicotine-and placebo-treated animals. Blood pressure (
in mm Hg) increased throughout a 3-week treatment period in nicotine-t
reated animals and was significantly higher (P<.05 by two-way ANOVA) t
han in placebo-treated rats, Blood pressure returned to normal within
1 week following exhaustion of the pellets. Oral glucose tolerance tes
ts performed 2,5 weeks after pellet placement showed similar glucose,
insulin, and free fatty acid (FFA) profiles by two-way ANOVA. In summa
ry, smokeless nicotine exposure leads to sustained but reversible hype
rtension without deterioration in glucose tolerance or insulin action
when weight gain is controlled, We conclude that in rats smokeless nic
otine adversely affects the coronary risk profile by increasing blood
pressure. Copyright (C) 1997 by W.B. Saunders Company.